ParkinsonFranceV1, PascalFrancis, Curation, bibRecord, 001643

GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys

Identifieur interne : 001643 ( PascalFrancis/Curation ); précédent : 001642; suivant : 001644

GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys

Auteurs : M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Y. Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del Rio

Source :

Neuroscience [ 0306-4522 ] ; 1993.

RBID : Pascal:93-0673676

Descripteurs français

Pascal (Inist)
- Survie, Mésencéphale, Neurone dopaminergique, Neurotoxine, Parkinson maladie, Traitement, Modèle animal, Singe, Macaca fascicularis, MPTP, Ganglioside GM1.
Wicri :
- topic : Singe.

English descriptors

KwdEn :
- Animal model, Dopaminergic neuron, GM1 ganglioside, Macaca fascicularis, Midbrain, Monkey, Neurotoxin, Parkinson disease, Survival, Treatment.

Abstract

We have examined the influence of chronic GM-1 treatment (20 mg/kg i.m. for 16 consecufive days) on the extent of dopaminergic damage induced by acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in cynomolgus monkeys using immunohistochemical and neurochemical analysis. The total number of tyrosine hydroxylase-immunoreactive neurons was reduced in different catecholaminergic mesencephalic regions of MPTP-treated monkeys such as substantia nigra pars compacta, mainly in the ventral portion of the nucleus (39% reduction), substantia nigra pars lateralis (31%), peri- and retrorubral catecholaminergic cell group and ventral tegmental area (A8 and A10 respectively, 20% reduction)

A01	`01`	`1`		`@0 0306-4522`
A02	`01`			`@0 NRSCDN`
A03		`1`		`@0 Neuroscience`
A05				`@2 56`
A06				`@2 4`
A08	`01`	`1`	`ENG`	`@1 GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys`
A11	`01`	`1`		`@1 HERRERO (M. T.)`
A11	`02`	`1`		`@1 PEREZ-OTANO (I.)`
A11	`03`	`1`		`@1 OSET (C.)`
A11	`04`	`1`		`@1 KASTNER (A.)`
A11	`05`	`1`		`@1 HIRSCH (E. C.)`
A11	`06`	`1`		`@1 AGID (Y.)`
A11	`07`	`1`		`@1 LUQUIN (M. R.)`
A11	`08`	`1`		`@1 OBESO (J. A.)`
A11	`09`	`1`		`@1 DEL RIO (J.)`
A14	`01`			`@1 INSERM, U289 @2 75013 Paris @3 FRA @Z 1 aut. @Z 4 aut. @Z 5 aut. @Z 6 aut.`
A20				`@1 965-972`
A21				`@1 1993`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 17194 @5 354000048190180160`
A44				`@0 0000`
A45				`@0 42 ref.`
A47	`01`	`1`		`@0 93-0673676`
A60				`@1 P`
A61				`@0 A`
A64		`1`		`@0 Neuroscience`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 We have examined the influence of chronic GM-1 treatment (20 mg/kg i.m. for 16 consecufive days) on the extent of dopaminergic damage induced by acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in cynomolgus monkeys using immunohistochemical and neurochemical analysis. The total number of tyrosine hydroxylase-immunoreactive neurons was reduced in different catecholaminergic mesencephalic regions of MPTP-treated monkeys such as substantia nigra pars compacta, mainly in the ventral portion of the nucleus (39% reduction), substantia nigra pars lateralis (31%), peri- and retrorubral catecholaminergic cell group and ventral tegmental area (A8 and A10 respectively, 20% reduction)
C02	`01`	`X`		`@0 002B17B`
C03	`01`	`X`	`FRE`	`@0 Survie @5 01`
C03	`01`	`X`	`ENG`	`@0 Survival @5 01`
C03	`01`	`X`	`SPA`	`@0 Sobrevivencia @5 01`
C03	`02`	`X`	`FRE`	`@0 Mésencéphale @5 02`
C03	`02`	`X`	`ENG`	`@0 Midbrain @5 02`
C03	`02`	`X`	`SPA`	`@0 Mesencéfalo @5 02`
C03	`03`	`X`	`FRE`	`@0 Neurone dopaminergique @5 03`
C03	`03`	`X`	`ENG`	`@0 Dopaminergic neuron @5 03`
C03	`03`	`X`	`SPA`	`@0 Neurona dopaminérgica @5 03`
C03	`04`	`X`	`FRE`	`@0 Neurotoxine @5 04`
C03	`04`	`X`	`ENG`	`@0 Neurotoxin @5 04`
C03	`04`	`X`	`SPA`	`@0 Neurotoxina @5 04`
C03	`05`	`X`	`FRE`	`@0 Parkinson maladie @2 NM @5 05`
C03	`05`	`X`	`ENG`	`@0 Parkinson disease @2 NM @5 05`
C03	`05`	`X`	`SPA`	`@0 Parkinson enfermedad @2 NM @5 05`
C03	`06`	`X`	`FRE`	`@0 Traitement @5 06`
C03	`06`	`X`	`ENG`	`@0 Treatment @5 06`
C03	`06`	`X`	`GER`	`@0 Aufbereiten @5 06`
C03	`06`	`X`	`SPA`	`@0 Tratamiento @5 06`
C03	`07`	`X`	`FRE`	`@0 Modèle animal @5 10`
C03	`07`	`X`	`ENG`	`@0 Animal model @5 10`
C03	`07`	`X`	`SPA`	`@0 Modelo animal @5 10`
C03	`08`	`X`	`FRE`	`@0 Singe @5 53`
C03	`08`	`X`	`ENG`	`@0 Monkey @5 53`
C03	`08`	`X`	`SPA`	`@0 Mono @5 53`
C03	`09`	`X`	`FRE`	`@0 Macaca fascicularis @2 NS @5 54`
C03	`09`	`X`	`ENG`	`@0 Macaca fascicularis @2 NS @5 54`
C03	`09`	`X`	`SPA`	`@0 Macaca fascicularis @2 NS @5 54`
C03	`10`	`X`	`FRE`	`@0 MPTP @4 INC @5 86`
C03	`11`	`X`	`FRE`	`@0 Ganglioside GM1 @4 CD @5 96`
C03	`11`	`X`	`ENG`	`@0 GM1 ganglioside @4 CD @5 96`
C07	`01`	`X`	`FRE`	`@0 Système nerveux central @5 20`
C07	`01`	`X`	`ENG`	`@0 Central nervous system @5 20`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso central @5 20`
C07	`02`	`X`	`FRE`	`@0 Maladie dégénérative @5 29`
C07	`02`	`X`	`ENG`	`@0 Degenerative disease @5 29`
C07	`02`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 29`
C07	`03`	`X`	`FRE`	`@0 Système nerveux pathologie @5 30`
C07	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 30`
C07	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 30`
C07	`04`	`X`	`FRE`	`@0 Primates @2 NS`
C07	`04`	`X`	`ENG`	`@0 Primates @2 NS`
C07	`04`	`X`	`SPA`	`@0 Primates @2 NS`
C07	`05`	`X`	`FRE`	`@0 Mammalia @2 NS`
C07	`05`	`X`	`ENG`	`@0 Mammalia @2 NS`
C07	`05`	`X`	`SPA`	`@0 Mammalia @2 NS`
C07	`06`	`X`	`FRE`	`@0 Vertebrata @2 NS`
C07	`06`	`X`	`ENG`	`@0 Vertebrata @2 NS`
C07	`06`	`X`	`SPA`	`@0 Vertebrata @2 NS`
C07	`07`	`X`	`FRE`	`@0 Simioidea @2 NS`
C07	`07`	`X`	`ENG`	`@0 Simioidea @2 NS`
C07	`07`	`X`	`SPA`	`@0 Simioidea @2 NS`
N21				`@1 342`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001A08

Links to Exploration step

Pascal:93-0673676

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys</title>
<author><name sortKey="Herrero, M T" sort="Herrero, M T" uniqKey="Herrero M" first="M. T." last="Herrero">M. T. Herrero</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Perez Otano, I" sort="Perez Otano, I" uniqKey="Perez Otano I" first="I." last="Perez-Otano">I. Perez-Otano</name>
</author>
<author><name sortKey="Oset, C" sort="Oset, C" uniqKey="Oset C" first="C." last="Oset">C. Oset</name>
</author>
<author><name sortKey="Kastner, A" sort="Kastner, A" uniqKey="Kastner A" first="A." last="Kastner">A. Kastner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Luquin, M R" sort="Luquin, M R" uniqKey="Luquin M" first="M. R." last="Luquin">M. R. Luquin</name>
</author>
<author><name sortKey="Obeso, J A" sort="Obeso, J A" uniqKey="Obeso J" first="J. A." last="Obeso">J. A. Obeso</name>
</author>
<author><name sortKey="Del Rio, J" sort="Del Rio, J" uniqKey="Del Rio J" first="J." last="Del Rio">J. Del Rio</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">93-0673676</idno>
<date when="1993">1993</date>
<idno type="stanalyst">PASCAL 93-0673676 INIST</idno>
<idno type="RBID">Pascal:93-0673676</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001A08</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001643</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys</title>
<author><name sortKey="Herrero, M T" sort="Herrero, M T" uniqKey="Herrero M" first="M. T." last="Herrero">M. T. Herrero</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Perez Otano, I" sort="Perez Otano, I" uniqKey="Perez Otano I" first="I." last="Perez-Otano">I. Perez-Otano</name>
</author>
<author><name sortKey="Oset, C" sort="Oset, C" uniqKey="Oset C" first="C." last="Oset">C. Oset</name>
</author>
<author><name sortKey="Kastner, A" sort="Kastner, A" uniqKey="Kastner A" first="A." last="Kastner">A. Kastner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Luquin, M R" sort="Luquin, M R" uniqKey="Luquin M" first="M. R." last="Luquin">M. R. Luquin</name>
</author>
<author><name sortKey="Obeso, J A" sort="Obeso, J A" uniqKey="Obeso J" first="J. A." last="Obeso">J. A. Obeso</name>
</author>
<author><name sortKey="Del Rio, J" sort="Del Rio, J" uniqKey="Del Rio J" first="J." last="Del Rio">J. Del Rio</name>
</author>
</analytic>
<series><title level="j" type="main">Neuroscience</title>
<title level="j" type="abbreviated">Neuroscience</title>
<idno type="ISSN">0306-4522</idno>
<imprint><date when="1993">1993</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Neuroscience</title>
<title level="j" type="abbreviated">Neuroscience</title>
<idno type="ISSN">0306-4522</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal model</term>
<term>Dopaminergic neuron</term>
<term>GM1 ganglioside</term>
<term>Macaca fascicularis</term>
<term>Midbrain</term>
<term>Monkey</term>
<term>Neurotoxin</term>
<term>Parkinson disease</term>
<term>Survival</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Survie</term>
<term>Mésencéphale</term>
<term>Neurone dopaminergique</term>
<term>Neurotoxine</term>
<term>Parkinson maladie</term>
<term>Traitement</term>
<term>Modèle animal</term>
<term>Singe</term>
<term>Macaca fascicularis</term>
<term>MPTP</term>
<term>Ganglioside GM1</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Singe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We have examined the influence of chronic GM-1 treatment (20 mg/kg i.m. for 16 consecufive days) on the extent of dopaminergic damage induced by acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in cynomolgus monkeys using immunohistochemical and neurochemical analysis. The total number of tyrosine hydroxylase-immunoreactive neurons was reduced in different catecholaminergic mesencephalic regions of MPTP-treated monkeys such as substantia nigra pars compacta, mainly in the ventral portion of the nucleus (39% reduction), substantia nigra pars lateralis (31%), peri- and retrorubral catecholaminergic cell group and ventral tegmental area (A8 and A10 respectively, 20% reduction)</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0306-4522</s0>
</fA01>
<fA02 i1="01"><s0>NRSCDN</s0>
</fA02>
<fA03 i2="1"><s0>Neuroscience</s0>
</fA03>
<fA05><s2>56</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>HERRERO (M. T.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>PEREZ-OTANO (I.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>OSET (C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>KASTNER (A.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>HIRSCH (E. C.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>AGID (Y.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>LUQUIN (M. R.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>OBESO (J. A.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>DEL RIO (J.)</s1>
</fA11>
<fA14 i1="01"><s1>INSERM, U289</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA20><s1>965-972</s1>
</fA20>
<fA21><s1>1993</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>17194</s2>
<s5>354000048190180160</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>42 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>93-0673676</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Neuroscience</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We have examined the influence of chronic GM-1 treatment (20 mg/kg i.m. for 16 consecufive days) on the extent of dopaminergic damage induced by acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in cynomolgus monkeys using immunohistochemical and neurochemical analysis. The total number of tyrosine hydroxylase-immunoreactive neurons was reduced in different catecholaminergic mesencephalic regions of MPTP-treated monkeys such as substantia nigra pars compacta, mainly in the ventral portion of the nucleus (39% reduction), substantia nigra pars lateralis (31%), peri- and retrorubral catecholaminergic cell group and ventral tegmental area (A8 and A10 respectively, 20% reduction)</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17B</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Survie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Survival</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sobrevivencia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Mésencéphale</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Midbrain</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Mesencéfalo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Neurone dopaminergique</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Dopaminergic neuron</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Neurona dopaminérgica</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Neurotoxine</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Neurotoxin</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Neurotoxina</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Modèle animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Animal model</s0>
<s5>10</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Modelo animal</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Singe</s0>
<s5>53</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Monkey</s0>
<s5>53</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Mono</s0>
<s5>53</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Macaca fascicularis</s0>
<s2>NS</s2>
<s5>54</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Macaca fascicularis</s0>
<s2>NS</s2>
<s5>54</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Macaca fascicularis</s0>
<s2>NS</s2>
<s5>54</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>MPTP</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Ganglioside GM1</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>GM1 ganglioside</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>20</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>20</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>20</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>29</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>29</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>29</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>30</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>30</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>30</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Primates</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Simioidea</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Simioidea</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Simioidea</s0>
<s2>NS</s2>
</fC07>
<fN21><s1>342</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001643 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001643 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:93-0673676
   |texte=   GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys

GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri